Please login to the form below

Not currently logged in
Email:
Password:

insulin

This page shows the latest insulin news and features for those working in and with pharma, biotech and healthcare.

Sanofi exits Zynquista alliance with Lexicon

Sanofi exits Zynquista alliance with Lexicon

The Sanofi/Lexicon partnered drug for type 1 diabetes was being co-developed as an add-on therapy to insulin injections to help improve blood sugar control. ... Zynquista was a key element in Sanofi’s plans to rebuild its diabetes franchise following

Latest news

  • Democrats reveal pricing plan with 250-drug hit list Democrats reveal pricing plan with 250-drug hit list

    tot the negotiation process – including insulins”. ... Insulin pricing has become a  highly charged issue in the US amid reports of patients who are struggling to afford the injections rationing their doses, and putting themselves at risk of

  • Novo follows Sanofi, Lilly with insulin price cut in US Novo follows Sanofi, Lilly with insulin price cut in US

    which offered a 50% cheaper version of its Humalog (insulin lispro) the following month. ... The reductions come after the average wholesale price of four of the most popular insulins more than tripled between 2007 and 2017.

  • Novo Nordisk shareholder revolt reaches Europe Novo Nordisk shareholder revolt reaches Europe

    At the heart of the dispute are claims that the Danish drugmaker wasn’t completely transparent about the pricing pressure on insulin from healthcare payers in the US. ... skyrocketing prices for the insulin products over the past decade”, according

  • Novo Nordisk boosted by new type 2 diabetes launches Novo Nordisk boosted by new type 2 diabetes launches

    Insulin sales were down 1% at constant exchange rates (CER) from the second quarter of 2018, but overall the company grew in sales by 5% CER and has raised its ... According to Novo Nordisk, the sales decline of insulin was driven by declining sales and

  • White House unveils plans to reimport medicines from Canada White House unveils plans to reimport medicines from Canada

    The plan would allow the import of of certain categories of lower cost drugs from Canada, but would exclude all biologic drugs (including insulin), intravenous drugs and controlled substances. ... A second pathway would allow manufacturers to import

More from news
Approximately 70 fully matching, plus 449 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Three strategies for managing loss of exclusivity successfully

    The history of insulin captures one of the mystifying complexities of the pharmaceutical market — how long-standing drugs become more expensive with time and competition fails to hold down prices. ... However, 2019 saw Eli Lilly respond to criticism of

  • The impossible launch

    th. century, those who discovered insulin, antibiotics, IVF, polio vaccine, the contraceptive pill to name a few, have made incredible positive changes to people’s lives across the planet.

  • MIT reveals new pill to deliver insulin

    Alex:This device enables the delivery of all biologic drugs, not just insulin. ... I tested the loading capacity of the device and optimised the analytical methods to quantify insulin.

  • How Medisafe is using AI to improve patient adherence

    OS: Back in 2012, my father – who is diabetic – came to me with a question, which was “have you seen me inject my insulin?”. ... I gave him a quick answer, “no, I haven’t seen you take your insulin.” Unfortunately, he took it to mean, “no,

  • How Medisafe is using AI to improve patient adherence

    OS: Back in 2012, my father – who is diabetic – came to me with a question, which was “have you seen me inject my insulin?”. ... I gave him a quick answer, “no, I haven’t seen you take your insulin.” Unfortunately, he took it to mean, “no,

More from PMHub
Approximately 1 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics